Biography
Meet Steven Goldberg, MD, MBA: Chief Medical Officer
Dr. Steven Goldberg • Sep. 24, 2024 • Updated Jan. 14, 2026
Steven Goldberg, MD, MBA serves as Chief Medical Officer at HealthTrack, where he is at the forefront of advancing clinically appropriate, next-morning diagnostic solutions that empower providers and improve patient outcomes. With a career defined by excellence in clinical practice, healthcare leadership, and strategic innovation, Dr. Goldberg is committed to improving population health through accuracy, speed, and evidence-based care.
In 2026, Dr. Goldberg was named a Health Care Hero by Louisville Business First, recognized in the Manager category for his leadership and impact on healthcare delivery in the Louisville community and beyond. This honor reflects his sustained commitment to clinical excellence, organizational leadership, and advancing meaningful improvements across the healthcare system.
Previously, Dr. Goldberg was recognized by Modern Healthcare as one of the 100 Most Influential People in Healthcare in 2020, ranking #39 nationally. During the COVID-19 pandemic, he played a pivotal role in addressing employee health, safety, and access to care, reinforcing his reputation as a trusted physician leader capable of navigating complex, high-stakes healthcare challenges.
A practicing primary care and urgent care physician, Dr. Goldberg bridges the gap between frontline clinical realities and system-level strategy. In his role at HealthTrack, he serves as the organization’s clinical strategist, guiding collaboration with medical directors and clinical leaders and building a robust foundation of peer-reviewed evidence to support diagnostic innovation. HealthTrack’s next-morning diagnostic insights help reshape outpatient workflows by accelerating accurate diagnoses, optimizing treatment decisions, and supporting responsible antibiotic use.
Dr. Goldberg is widely regarded as a national medical thought leader and trusted media voice. He has been featured in more than 100 health and business publications, including Yahoo! News, MSN, The Daily Mail, FOX News, AOL, Newsweek, Parade, Healthline, CNET, and The Business Journals, among others. He also serves as a regular weekly medical contributor on FOX 5 (DMV Zone) in Washington, DC, and has participated in over 50 broadcast media interviews nationwide, offering expert commentary on clinical care, public health, and healthcare system performance.
Beyond diagnostics and media, Dr. Goldberg is known for fostering cultures of empowerment, mentorship, and accountability within complex healthcare organizations. His leadership style emphasizes collaboration, clinical integrity, and measurable outcomes, enabling teams to perform at the highest level in dynamic environments.
Dr. Goldberg lives in Louisville with his family. His clinical practice is affiliated with University of Louisville Health. He has previously served in senior physician executive roles at Quest Diagnostics, WellCare, Humana, and Aetna.
Manuscripts
1. French AJ, Fragala MS, Evans A, Upadhyay P, Goldberg SE, Reddy J. Real world evaluation of next-day molecular respiratory infectious disease testing on healthcare resource utilization and costs. ClinicoEconomics and Outcomes Research 2024. (In review) (Impact Factor: 2.1)
2. Evans A, Doshi R, Yeaw J, Coyle K, Steven Goldberg SE, Wang E, Fragala MS, Reddy J. Healthcare resource utilization and costs among patients receiving diagnostic tests for respiratory infections. American Journal of Managed Care 2024. (In review) (Impact Factor: 3.2)
3. Alexander BD, Hanson KE, Rosato AE, Nash DB, Fragala MS, Goldberg SE. Critical Need for Antibiotic Stewardship in Urgent Care: Role of Emerging Molecular Diagnostics. Journal of Urgent Care Medicine 2024. (In revision)
4. Evans A, Singh V, Upadhyay P, Fragala MS, French AJ, Goldberg SE, Reddy J. Molecular Testing for Respiratory Tract Infections: Real-world Impact on Healthcare Costs. Am J Inf Dis 2024. (In revision) (Impact Factor: 3.1)
5. Alexander BD, Irish W, Rosato AE, Eisenstein BI, Fragala MS, Goldberg SE, Nash DB. Is Pathogen Molecular Testing Reshaping Outpatient Antibiotic Prescribing? American Journal of Medical Quality 2024. (In revision) (Impact Factor: 1.0)
6. Evans A, Doshi R, Yeaw J, Coyle K, Goldberg SE, Wang E, Fragala MS, Reddy J. Healthcare Utilization and Costs Following PCR Diagnostic Testing Among Patients with Vaginitis The Journal of Comparative Effectiveness Research 2024. (In press) (Impact Factor: 2.1)
7. Evans A, Singh V, Upadhyay P, Fragala MS, Upadhyay P, French AJ, Goldberg SE, Reddy J. Molecular Testing for Women’s Gynecologic Health: Real-World Impact on Health Care Costs. Population Health Management 2024. 2 October 2024. https://doi.org/10.1089/pop.2024.0133. (Impact Factor: 2.0)
8. Evans A, Fragala, MS, Upadhyay P, French AJ, Goldberg SE, Reddy J. Utilization of Syndromic Vaginitis Diagnostic Testing Reduces 6-Month Follow-Up Outpatient Service Healthcare Costs—A Real-World Data Analysis. Healthcare 2024, 12(22), 2204; https://doi.org/10.3390/healthcare12222204. (Impact Factor: 2.4)
9. Fragala MS, Keogh M, Goldberg SE, Lorenz RA, Shaman JA. Clinical and economic outcomes of a pharmacogenomics-enriched comprehensive medication management program in a self-insured employee population. Pharmacogenomics J 24, 30 (2024). https://doi.org/10.1038/s41397-024-00350-1. (Impact Factor: 13.8)
10. Goldberg SE, Fragala MS. Health Care Bricolage: A Method to Reduce High-Cost Medical Spend. Population Health Management. 2024. https://doi.org/10.1089/pop.2024.0008 (Impact Factor 2.5)
11. Haji-Sheikhi F, Fragala MS, Bare LA, Rowland CM, Goldberg SE. Prediction of Future Medical Costs by Modifiable Measures of Health. Clinicoecon Outcomes Res. 2023 Jun 30;15:525-534. (Impact Factor: 0.445)
12. Keogh M, Fragala MS, Peter AP, Lorenz RA, Goldberg SE, Shaman JA. Early Insights From a Pharmacogenomic-Enriched Comprehensive Medication Management Program Implementation in an Adult Employee Population. J Occup Environ Med. 2022 Dec 1;64(12):e818-e822.
13. Fragala MS, Shaman JA, Lorenz RA, Goldberg SE. Role of Pharmacogenomics in Comprehensive Medication Management: Considerations for Employers. Popul Health Manag. 2022 Dec;25(6):753-762.
14. Fragala MS, Goldberg Z Goldberg, SE. Return to Work: Managing Employee Population Health During the COVID-19 Pandemic. Population Health Management. Manag. 2021 Feb;24(S1):S3-S15. (Impact Factor: 2.09)
15. Plantes PJ, Fragala MS, Clarke C, Goldberg ZN, Radcliff J, Goldberg SE. Model for Mitigation of Workplace Transmission of COVID-19 Through Population-Based Testing and Surveillance. Popul Health Manag. 2021 Feb;24(S1):S16-S25. (Impact Factor: 2.09)
16. Goldberg SE, Fragala MS, Wohlgemuth JG. Self-insured Employer Health Benefits Strategy Established a Negative Cost Trend While Improving Performance. Population Health Management. 2019 Dec;22(6):547-554. (Impact Factor: 1.26)
Related Articles and White papers
Dr. Steven Goldberg • Sep. 24, 2024 • Updated Jan. 14, 2026
Steven Goldberg, MD, MBA serves as Chief Medical Officer at HealthTrack, where he is at the forefront of advancing clinically appropriate, next-morning diagnostic solutions that empower providers and improve patient outcomes. With a career defined by excellence in clinical practice, healthcare leadership, and strategic innovation, Dr. Goldberg is committed to improving population health through accuracy, speed, and evidence-based care.
In 2026, Dr. Goldberg was named a Health Care Hero by Louisville Business First, recognized in the Manager category for his leadership and impact on healthcare delivery in the Louisville community and beyond. This honor reflects his sustained commitment to clinical excellence, organizational leadership, and advancing meaningful improvements across the healthcare system.
Previously, Dr. Goldberg was recognized by Modern Healthcare as one of the 100 Most Influential People in Healthcare in 2020, ranking #39 nationally. During the COVID-19 pandemic, he played a pivotal role in addressing employee health, safety, and access to care, reinforcing his reputation as a trusted physician leader capable of navigating complex, high-stakes healthcare challenges.
A practicing primary care and urgent care physician, Dr. Goldberg bridges the gap between frontline clinical realities and system-level strategy. In his role at HealthTrack, he serves as the organization’s clinical strategist, guiding collaboration with medical directors and clinical leaders and building a robust foundation of peer-reviewed evidence to support diagnostic innovation. HealthTrack’s next-morning diagnostic insights help reshape outpatient workflows by accelerating accurate diagnoses, optimizing treatment decisions, and supporting responsible antibiotic use.
Dr. Goldberg is widely regarded as a national medical thought leader and trusted media voice. He has been featured in more than 100 health and business publications, including Yahoo! News, MSN, The Daily Mail, FOX News, AOL, Newsweek, Parade, Healthline, CNET, and The Business Journals, among others. He also serves as a regular weekly medical contributor on FOX 5 (DMV Zone) in Washington, DC, and has participated in over 50 broadcast media interviews nationwide, offering expert commentary on clinical care, public health, and healthcare system performance.
Beyond diagnostics and media, Dr. Goldberg is known for fostering cultures of empowerment, mentorship, and accountability within complex healthcare organizations. His leadership style emphasizes collaboration, clinical integrity, and measurable outcomes, enabling teams to perform at the highest level in dynamic environments.
Dr. Goldberg lives in Louisville with his family. His clinical practice is affiliated with University of Louisville Health. He has previously served in senior physician executive roles at Quest Diagnostics, WellCare, Humana, and Aetna.
Manuscripts
1. French AJ, Fragala MS, Evans A, Upadhyay P, Goldberg SE, Reddy J. Real world evaluation of next-day molecular respiratory infectious disease testing on healthcare resource utilization and costs. ClinicoEconomics and Outcomes Research 2024. (In review) (Impact Factor: 2.1)
2. Evans A, Doshi R, Yeaw J, Coyle K, Steven Goldberg SE, Wang E, Fragala MS, Reddy J. Healthcare resource utilization and costs among patients receiving diagnostic tests for respiratory infections. American Journal of Managed Care 2024. (In review) (Impact Factor: 3.2)
3. Alexander BD, Hanson KE, Rosato AE, Nash DB, Fragala MS, Goldberg SE. Critical Need for Antibiotic Stewardship in Urgent Care: Role of Emerging Molecular Diagnostics. Journal of Urgent Care Medicine 2024. (In revision)
4. Evans A, Singh V, Upadhyay P, Fragala MS, French AJ, Goldberg SE, Reddy J. Molecular Testing for Respiratory Tract Infections: Real-world Impact on Healthcare Costs. Am J Inf Dis 2024. (In revision) (Impact Factor: 3.1)
5. Alexander BD, Irish W, Rosato AE, Eisenstein BI, Fragala MS, Goldberg SE, Nash DB. Is Pathogen Molecular Testing Reshaping Outpatient Antibiotic Prescribing? American Journal of Medical Quality 2024. (In revision) (Impact Factor: 1.0)
6. Evans A, Doshi R, Yeaw J, Coyle K, Goldberg SE, Wang E, Fragala MS, Reddy J. Healthcare Utilization and Costs Following PCR Diagnostic Testing Among Patients with Vaginitis The Journal of Comparative Effectiveness Research 2024. (In press) (Impact Factor: 2.1)
7. Evans A, Singh V, Upadhyay P, Fragala MS, Upadhyay P, French AJ, Goldberg SE, Reddy J. Molecular Testing for Women’s Gynecologic Health: Real-World Impact on Health Care Costs. Population Health Management 2024. 2 October 2024. https://doi.org/10.1089/pop.2024.0133. (Impact Factor: 2.0)
8. Evans A, Fragala, MS, Upadhyay P, French AJ, Goldberg SE, Reddy J. Utilization of Syndromic Vaginitis Diagnostic Testing Reduces 6-Month Follow-Up Outpatient Service Healthcare Costs—A Real-World Data Analysis. Healthcare 2024, 12(22), 2204; https://doi.org/10.3390/healthcare12222204. (Impact Factor: 2.4)
9. Fragala MS, Keogh M, Goldberg SE, Lorenz RA, Shaman JA. Clinical and economic outcomes of a pharmacogenomics-enriched comprehensive medication management program in a self-insured employee population. Pharmacogenomics J 24, 30 (2024). https://doi.org/10.1038/s41397-024-00350-1. (Impact Factor: 13.8)
10. Goldberg SE, Fragala MS. Health Care Bricolage: A Method to Reduce High-Cost Medical Spend. Population Health Management. 2024. https://doi.org/10.1089/pop.2024.0008 (Impact Factor 2.5)
11. Haji-Sheikhi F, Fragala MS, Bare LA, Rowland CM, Goldberg SE. Prediction of Future Medical Costs by Modifiable Measures of Health. Clinicoecon Outcomes Res. 2023 Jun 30;15:525-534. (Impact Factor: 0.445)
12. Keogh M, Fragala MS, Peter AP, Lorenz RA, Goldberg SE, Shaman JA. Early Insights From a Pharmacogenomic-Enriched Comprehensive Medication Management Program Implementation in an Adult Employee Population. J Occup Environ Med. 2022 Dec 1;64(12):e818-e822.
13. Fragala MS, Shaman JA, Lorenz RA, Goldberg SE. Role of Pharmacogenomics in Comprehensive Medication Management: Considerations for Employers. Popul Health Manag. 2022 Dec;25(6):753-762.
14. Fragala MS, Goldberg Z Goldberg, SE. Return to Work: Managing Employee Population Health During the COVID-19 Pandemic. Population Health Management. Manag. 2021 Feb;24(S1):S3-S15. (Impact Factor: 2.09)
15. Plantes PJ, Fragala MS, Clarke C, Goldberg ZN, Radcliff J, Goldberg SE. Model for Mitigation of Workplace Transmission of COVID-19 Through Population-Based Testing and Surveillance. Popul Health Manag. 2021 Feb;24(S1):S16-S25. (Impact Factor: 2.09)
16. Goldberg SE, Fragala MS, Wohlgemuth JG. Self-insured Employer Health Benefits Strategy Established a Negative Cost Trend While Improving Performance. Population Health Management. 2019 Dec;22(6):547-554. (Impact Factor: 1.26)
